News


All series


All News

Vistakon has created a new professional development group that combines its professional affairs, ODLean consulting program, and optometry school educational efforts into one department.

The FDA has approved Rescula (unoprostone isopropyl ophthalmic solution, Sucampo Pharmaceuticals Inc.) 0.15%, an sNDA for lowering IOP in patients with open-angle glaucoma or ocular hypertension.

With hopes for helping humans to see, researchers announced promising results after transplanting photoreceptor precursor cells into mouse retinas.

Aspirin and AMD

Chief Optometric Editor Dr. Ernie Bowling shares an encounter with a patient asking about the safety of taking aspirin due to risk of AMD.

You have a voice

Chief Optometric Editor Ernie Bowling extends an offer to News Flash and Optometry Times readers.

Direct your glaucoma patients to a new consumer-friendly Web site developed by the Glaucoma Foundation, the Alliance for Aging Research, and Merck.